NCT02076451 2019-02-12Open-label Study of DS-8273a to Assess Its Safety and Tolerability, and Assess Its Pharmacokinetic and Pharmacodynamic Properties in Subjects With Advanced Solid Tumors or LymphomasDaiichi SankyoPhase 1 Completed32 enrolled